Q Bio

Q Bio

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.q.bio

Last Round

Strategic

Jul 18, 2024

Est. Valuation

$140M

Total Funding Raised

$85M

Momentum Score

25 /100

Company Overview

Q Bio is a healthcare technology company that operates a clinical digital twin platform to evaluate patients' medical histories and identify their current and future health risks through whole-body scans and advanced simulations.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Imaging, Medical AI, Healthcare Analytics, Medical Devices

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

clinical digital twinfull-body scanwhole-body MRIpreventive healthcareearly disease detectionquantitative MRImedical imaging AIprecision medicinefull-body scannerhealth risk assessmentexecutive physicallongitudinal health trackingTensor Field MappingTFMhealthcare SaaSdiagnostic equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Q Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Q Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 18, 2024
VC RoundApr 29, 2021
Series BFeb 20, 2020
Series AFeb 1, 2018
SeedNov 2, 2016

Key People

Founding team and executive leadership

Jeffrey Brewer

Chief Executive Officer

Executive Team

George Zamanakos

Chief Operating Officer

Executive Team

Q Bio Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzStrategic, VC Round, Seed, Series B
SciFi VenturesSeries B, VC Round
Khosla VenturesStrategic, Series B, VC Round
Founders FundStrategic, Series B, VC Round
Thirty Five VenturesSeries B
Beast VenturesSeries B, VC Round
Kaiser Foundation HospitalsStrategic, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2021

    Completed a VC Round funding round.

Q Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Q Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Q Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range40
Year Founded2015
Last FundingJul 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.